Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome

BACKGROUND: Dystonia is a key symptom in corticobasal syndrome (CBS), and upper limb dystonia is the most common phenotype. Dystonia‐associated pain is frequently reported and can be disabling, with poor benefit from oral treatments. AIMS OF THE STUDY: To investigate the role of botulinum toxin A (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Unti, Elisa, Mazzucchi, Sonia, Calabrese, Rosanna, Palermo, Giovanni, Del Prete, Eleonora, Bonuccelli, Ubaldo, Ceravolo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576166/
https://www.ncbi.nlm.nih.gov/pubmed/31074111
http://dx.doi.org/10.1002/brb3.1182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576166/
https://www.ncbi.nlm.nih.gov/pubmed/31074111
http://dx.doi.org/10.1002/brb3.1182

Ejemplares similares